Cystic fibrosis year in review 2019: Section 1 CFTR modulators.

Adrienne P Savant, Susanna A McColley

Pediatric pulmonology 2020 Dec

filter terms:

During the year 2019, research and case reports/series in the field of cystic fibrosis (CF) were in abundance. To adequately address the large body of CF research published during 2019, the CF year in review will be divided into three sections. This report is the first section, focusing specifically on new research related to cystic fibrosis transmembrane conductance regulator modulator therapy. Additional sections will concentrate on pulmonary and infections research and the multisystem effects of CF. It is an exciting time to be providing care for patients and their families with CF with all the exciting new discoveries that will be shared in these reviews. © 2020 Wiley Periodicals LLC.

Citation

Adrienne P Savant, Susanna A McColley. Cystic fibrosis year in review 2019: Section 1 CFTR modulators. Pediatric pulmonology. 2020 Dec;55(12):3236-3242